RSSCategory: Histology

Digital Pathology Association Session to Take Place at 29th European Congress of Pathology

| July 5, 2017 | 0 Comments

SAVE THE DATE! DIGITAL PATHOLOGY ASSOCIATION SESSION To take place at the 29th European Congress of Pathology Sunday, September 3, 2017 | 2:45-5:15 PM Amsterdam, The Netherlands Presentations Include: Computational Pathology and Interoperability to advance Digital Pathology Esther Abels, MSc Philips Digital Pathology Solutions   Automated IA of Immunohistochemistry as a Biomarker for Immuno-oncology Michael Montalto, PhD Bristol-Myers Squibb […]

Continue Reading

PathVision Helping Pathology

| June 28, 2017 | 0 Comments

Faxitron has released a new video highlighting their PathVision in use at Allina Health in Minneapolis. The video discusses how direct imaging of breast pathology specimens in the gross room facilitate coordinated care with radiology and surgery colleagues to identify mass lesions, surgical clips, localization wires and radioactive seeds. This multi-disciplinary approach with real-time specimen […]

Continue Reading

HalioDx receives CLIA Compliance for Immunoscore® Colon

| June 21, 2017 | 0 Comments

HalioDx receives CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a turnaround time of 10 days Marseille, June 21, 2017 – HalioDx announced today that the company is compliant under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for its Marseille-based full service […]

Continue Reading

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

How to Use Deep Learning AI for Context-Intelligent Image Analysis – Join Our Webinar on June 1st

| May 19, 2017 | 0 Comments

Recent advances in artificial intelligence (AI) show great promise in several fields of medicine. In particular, the field of Deep Learning is enabling the development of expert-level automated algorithms. Successful applications include AI-supported diagnosis of melanoma based on pictures of skin lesions and diabetic retinopathy in images of the retina. Human expert judgement augmented by […]

Continue Reading

Webinar: Panoptiq Use Cases in Pathology

| May 16, 2017 | 1 Comment

Matthew G Hanna, M.D., Clinical Instructor of Pathology Informatics, University of Pittsburgh Wed, May 17th, 2017 2:00PM EST Join Dr. Matthew Hanna, MD, Pathologist and Clinical Instructor of Pathology Informatics at the University of Pittsburgh, as he discusses multiple use cases for Panoptiq. Panoptiq takes a software-based approach to digital imaging, and as such integrates […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Leica Biosystems Applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance of Digital Pathology

| May 11, 2017 | 0 Comments

VISTA, CA – May 11, 2017 – The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite™ Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA) on this positive outcome from […]

Continue Reading

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Hørsholm, Denmark, May 3rd – Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning an important technological breakthrough for tissue pathology that offers the potential to make a real difference in the assessment of […]

Continue Reading

HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging

Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop deep-learning algorithms to analyze 500 whole-slide H&E lymph node images and calculate TNM staging of 100 breast cancer patients. The HALO Deep Learning solution was the […]

Continue Reading

Proscia Takes on Subjectivity in Pathology Through AI Innovation

| April 27, 2017 | 0 Comments

Proscia continues to demonstrate the potential for its technology demonstrating agreement between its algorithms and pathologist reads in detection and classification of breast cancer. Proscia Inc., a data and analytics solutions provider for digital pathology, today announced their digital pathology technology has the potential to eliminate subjectivity in the detection and classification of breast cancer. Using […]

Continue Reading

ContextVision Secures Large-Scale Data Source for Digital Pathology Research and Development

| April 6, 2017 | 0 Comments

STOCKHOLM – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has started a collaboration and signed an agreement with ALABplus, one of Poland’s largest provider of pathology services, to secure access to a significant amount of data for deep learning product development within digital pathology. “The present contract is extremely valuable for ContextVision as we […]

Continue Reading